Muruganandah V - Search Results

1

Identification and Characterization of a Peptide from the Stony Coral Heliofungia actiniformis.

Schmidt CA, Wilson DT, Cooke I, Potriquet J, Tungatt K, Muruganandah V, Boote C, Kuek F, Miles JJ, Kupz A, Ryan S, Loukas A, Bansal PS, Takjoo R, Miller DJ, Peigneur S, Tytgat J, Daly NL. Schmidt CA, et al. Among authors: muruganandah v. J Nat Prod. 2020 Nov 25;83(11):3454-3463. doi: 10.1021/acs.jnatprod.0c00981. Epub 2020 Nov 9. J Nat Prod. 2020. PMID: 33166137

2

Immune responses to bacterial lung infections and their implications for vaccination.

Muruganandah V, Kupz A. Muruganandah V, et al. Int Immunol. 2022 Apr 20;34(5):231-248. doi: 10.1093/intimm/dxab109. Int Immunol. 2022. PMID: 34850883 Review.

3

What lies beneath the airway mucosal barrier? Throwing the spotlight on antigen-presenting cell function in the lower respiratory tract.

Pai S, Muruganandah V, Kupz A. Pai S, et al. Among authors: muruganandah v. Clin Transl Immunology. 2020 Jul 23;9(7):e1158. doi: 10.1002/cti2.1158. eCollection 2020. Clin Transl Immunology. 2020. PMID: 32714552 Free PMC article. Review.

4

A Systematic Review: The Role of Resident Memory T Cells in Infectious Diseases and Their Relevance for Vaccine Development.

Muruganandah V, Sathkumara HD, Navarro S, Kupz A. Muruganandah V, et al. Front Immunol. 2018 Jul 9;9:1574. doi: 10.3389/fimmu.2018.01574. eCollection 2018. Front Immunol. 2018. PMID: 30038624 Free PMC article.

5

A systematic approach to simultaneously evaluate safety, immunogenicity, and efficacy of novel tuberculosis vaccination strategies.

Muruganandah V, Sathkumara HD, Pai S, Rush CM, Brosch R, Waardenberg AJ, Kupz A. Muruganandah V, et al. Sci Adv. 2020 Mar 4;6(10):eaaz1767. doi: 10.1126/sciadv.aaz1767. eCollection 2020 Mar. Sci Adv. 2020. PMID: 32181361 Free PMC article.

6

Mucosal delivery of ESX-1-expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes.

Sathkumara HD, Muruganandah V, Cooper MM, Field MA, Alim MA, Brosch R, Ketheesan N, Govan B, Rush CM, Henning L, Kupz A. Sathkumara HD, et al. Among authors: muruganandah v. Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20848-20859. doi: 10.1073/pnas.2003235117. Epub 2020 Aug 10. Proc Natl Acad Sci U S A. 2020. PMID: 32778586 Free PMC article.

7

ESX-5-targeted export of ESAT-6 in BCG combines enhanced immunogenicity & efficacy against murine tuberculosis with low virulence and reduced persistence.

Heijmenberg I, Husain A, Sathkumara HD, Muruganandah V, Seifert J, Miranda-Hernandez S, Kashyap RS, Field MA, Krishnamoorthy G, Kupz A. Heijmenberg I, et al. Among authors: muruganandah v. Vaccine. 2021 Dec 8;39(50):7265-7276. doi: 10.1016/j.vaccine.2021.08.030. Epub 2021 Aug 19. Vaccine. 2021. PMID: 34420788

8

QuantiFERON Gold-In-Tube for the diagnosis of mycobacterial tuberculosis infection in children under 5 years of age: A systematic review and meta-analysis.

Volkman T, Muruganandah V, Graham H, Tosif S, Stokes S, Ranganathan S. Volkman T, et al. Among authors: muruganandah v. PLoS One. 2024 Jan 2;19(1):e0295913. doi: 10.1371/journal.pone.0295913. eCollection 2024. PLoS One. 2024. PMID: 38166111 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page